Last edition
News about "Zydus Lifesciences to disclose the manufacturing p"
Delhi HC Rejects Roche Plea to Disclose Zydus' Manufacturing Process for Breast Cancer Drug Sigrima
The Delhi High Court has declined to direct Zydus Lifesciences to disclose the manufacturing process of its breast cancer drug Sigrima, stating that F. Hoffmann-La Roche failed to meet the mandatory requirements under Section 104A of the Patents Act, 1970.
Zydus Lifesciences To Disclose The Manufacturing P | 26/07/2025 | By Darshana | 112
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members